Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

Clinical trial NCT03055286 · TERMINATED

Trial details

NCT number: NCT03055286
Sponsor: JW Pharmaceutical
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2017-02-06
Primary completion: 2025-08-26
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.